Cathie Wood, chief of Ark Investment Management, believes in tech stocks that will have a “disruptive” impact in the future.

EST Cathie Wood’s ARK Investment buys 77.6K shares of 10x Genomics (TXG) todayMaximize Your Portfolio with Data Driven Insights:Leverage ...

Cathie Wood, chief of Ark Investment Management, believes in tech stocks that will have a disruptive impact. She isn’t afraid ...

EST Cathie Wood’s ARK Investment buys 187K shares of Crispr Therapeutics (CRSP) todayMaximize Your Portfolio with Data Driven ...

ARK Invest's 13F portfolio value increased by ~10% to ~$12B this quarter. Check out the top holdings and new stakes of the ...

Cathie Wood, CEO and CIO of Ark Invest, highlighted that one of the dominant themes of 2025 will be ongoing investment in ...

Cathie Wood-led Ark Invest made significant trades involving CRSP, TXG, RBLX, ACHR, NU, ADYEY, ACCD, and AVAV.

Don’t look now, but Cathie Wood of Ark Invest is fresh off an impressive comeback year, with her broader basket of disruptive ...

In the latest trading session, Cathie Wood's ARK ETFs continued to adjust their portfolios, with significant moves seen in both buying and selling across various sectors. The largest transaction for ...

Cathie Wood says most profound application of AI is in healthcare. She particularly expects Recursion Pharma and Illumina to ...

Cathie Wood's ARK ETFs published their daily ... totaling $12,284,718 in value. This significant investment underscores ARK's continued confidence in the gene-editing company.